As of 2026-09-08, the Relative Valuation of ZIOPHARM Oncology Inc (ZIOP) is (9.40) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.87 USD, the upside of ZIOPHARM Oncology Inc based on Relative Valuation is -1186.0%.
The range of the Relative Valuation is (8.30) - (11.21) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.0x - 27.0x | 23.5x |
| Forward P/E multiples | 16.5x - 27.1x | 21.8x |
| Fair Price | (8.30) - (11.21) | (9.40) |
| Upside | -1059.0% - -1394.6% | -1186.0% |
| Date | P/E |